SWAYZE ERIC (SVP, Research) reported 1 transaction at IONIS PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 3/3/2026ACC: 0000874015-26-000125
Officer· SVP, Research
Since Jan 2020
+256.00
Net shares
Net buyer
$12.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
256.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+256.00
Price / share
$48.87
Trade value
$12.51K
% of position
0.8%
2/27/2026
32.10K→32.36K
Total
Net shares
+256.00
Net value
$12.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2026 | J · J | +256.00 | $48.87 | $12.51K | 0.8% | 32.10K | 32.36K |
| Total | +256.00 | $12.51K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned318.00
Total
318.00 indirect318.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 318.00 | Indirect |
| Total | 318.00 | 318.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported